Skip to main content

Table 1 Clinical and lifestyle background

From: Differential properties of KRAS transversion and transition mutations in non-small cell lung cancer: associations with environmental factors and clinical outcomes

 

KRAS WT (n = 794) No. (%)

Transversions (n = 61) No. (%)

P value*

Transitions (n = 19) No. (%)

P value^

P value#

Age median (range)

70.0 (23–92)

70.0 (49–85)

-

70.0 (52–86)

-

-

Sex

  

0.02

 

 < 0.01

0.65

 Male

366 (46.1)

39 (63.9)

 

13 (68.4)

  

 Female

428 (53.9)

22 (36.1)

 

6 (31.6)

  

Smoking

  

 < 0.01

 

 < 0.01

0.64

 Never

413 (52.0)

18 (29.5)

 

5 (26.3)

  

 Ever

381 (48.0)

43 (70.5)

 

14 (73.7)

  

Histology

  

0.01

 

0.01

1.00

 Sq

138 (17.4)

3 (4.9)

 

1 (5.3)

  

 Non-sq

656 (82.6)

58 (95.1)

 

18 (94.7)

  

Stage

  

0.30

 

0.84

0.77

 I

568 (71.5)

38 (62.3)

 

12 (63.1)

  

 II

114 (14.4)

12 (19.7)

 

3 (15.8)

  

 III

94 (11.8)

7 (11.5)

 

3 (15.8)

  

 IV

18 (2.3)

4 (6.5)

 

1 (5.3)

  

No. of Mutations

  

0.35

 

 < 0.01

0.04

 0

200 (25.2)

0

 

0

  

 1

384 (48.4)

35 (57.4)

 

8 (42.1)

  

 ≥ 2

210 (26.4)

26 (42.6)

 

11 (57.9)

  

BMI

  

0.01

 

0.06

0.39

 < 22.5

402 (50.6)

20 (32.8)

 

7 (36.9)

  

 ≥ 22.5

389 (49.0)

40 (65.6)

 

12 (63.1)

  

 Unknown

3 (0.4)

1 (1.6)

 

0

  

High fat diets

  

0.12

 

0.32

0.67

 ≤ 2/ week

313 (39.4)

31 (50.8)

 

9 (47.4)

  

 ≥ 3/ week

477 (60.1)

30 (49.2)

 

10 (52.6)

  

 Unknown

4 (0.5)

0

 

0

  

Vegetables

  

0.01

 

0.13

0.47

 ≤ 2/ week

62 (7.8)

13 (21.3)

 

3 (15.8)

  

 ≥ 3/ week

732 (92.2)

48 (78.7)

 

16 (84.2)

  

Fruits

  

0.02

 

0.14

0.48

 ≤ 2/ week

249 (31.4)

29 (47.5)

 

8 (42.1)

  

 ≥ 3/ week

545 (68.6)

32 (52.5)

 

11 (57.9)

  

Soy bean

  

0.05

 

0.84

0.12

 ≤ 2/ week

112 (14.1)

16 (26.2)

 

3 (15.8)

  

 ≥ 3/ week

681 (85.8)

45 (73.8)

 

16 (84.2)

  

 Unknown

1 (0.1)

0

 

0

  

Exercise

  

1.00

 

0.15

0.15

 ≤ 2/ week

409 (51.5)

32 (52.5)

 

12 (63.1)

  

 ≥ 3/ week

385 (48.5)

29 (47.5)

 

7 (36.9)

  
  1. Abbreviations: KRAS WT Kirsten rat sarcoma viral oncogene homolog wild-type, Sq squamous cell carcinoma, BMI body mass index
  2. *KRAS WT vs. transversions
  3. ^KRAS WT vs. transitions
  4. #transversions vs. transitions